E1 of the AOM/DSS-treated group with “Sex and KO” criteria comprised the gut microbiota of four male WT AOM/DSS-treated, four female WT AOM/DSS-treated, seven male Nrf2 KO AOM/DSS-treated, and three female Nrf2 KO AOM/DSS-treated mice. This evidence concerns the gene NFE2L2 and infectious otitis media.